Table 3 Additional patient samples used for RNAScope (Oslo cohort).
Clinical classification | Patient | Age | Gender | Anti-SSA/Ro | Anti-SSB/La | ANA | Schirmer test | Saliva secretion | Dry mouth | Dry eyes | FS | Germinal centers (CD21+) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-SS | Non-SSa | 42 | F | − | − | − | + | − | + | + | − | − |
Non-SSb | 47 | F | − | − | − | + | − | + | + | − | − | |
Non-SSc | 64 | F | − | − | − | − | + | + | + | − | − | |
Non-SSd | 25 | F | − | − | − | + | − | + | + | − | − | |
Non-SSe | 51 | F | − | − | − | + | + | + | + | − | − | |
Non-SSf | 38 | F | − | − | − | + | − | + | + | − | − | |
SS | SSa | 49 | F | + | + | + | + | + | + | + | 1 | − |
SSb | 30 | M | + | + | + | + | + | + | + | 1 | − | |
SSc | 38 | F | − | − | − | + | + | + | + | 2 | + | |
SSd | 79 | M | + | + | + | + | + | − | + | 1 | − | |
SSe | 59 | F | + | − | + | + | + | + | + | 1 | − |